Cantor Fitzgerald provided research reports on Cabaletta Bio, a company whose stock trades on Nasdaq.
1 report, 1 independent
Updated Aug 19
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald provided research reports on Cabaletta Bio, a company whose stock trades on Nasdaq.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cantor Fitzgerald
American financial services company
-
Nasdaq
American fully electronic stock exchange
Related events
- Cantor Fitzgerald affiliates organized a Special Purpose Acquisition Company (SPAC).
- Both Cantor Fitzgerald and Oppenheimer Holdings began covering Five Below stock.
- Cantor Fitzgerald disclosed a stock transaction involving Sonida Senior Living, Inc. in a legal filing on August 1, 2026.
- Generate Biomedicines Inc listed its shares on the Nasdaq exchange and received research notes and ratings from Cantor Fitzgerald.
- Cantor Fitzgerald raised its price target and rating for Supernus Pharmaceuticals, Inc. on September 2, 2026, and the company filed a disclosure with the SEC.